05.10.2020 • News

Showa Denko Merges European Units

Japan’s Showa Denko has decided to consolidate its two European subsidiaries to expand business operations in the region. Effective Jan. 1, 2021, Showa Denko Carbon Holding (SDCH) will take over Showa Denko Europe (SDE), becoming the surviving entity. It will then change its name to Showa Denko Europe.

The newly merged company will be headquartered in Wiesbaden, Germany, but will retain SDCH’s head office in Munich as a sales office.

SDCH operates its graphite electrode subsidiaries as a management company in Europe while SDE provides business support services to Showa Denko’s European subsidiaries, including import/export management, chemical substance management and marketing functions.

 

Author: Elaine Burridge, Freelance Journalist

Japan’s Showa Denko will consolidate its two European subsidiaries to expand...
Japan’s Showa Denko will consolidate its two European subsidiaries to expand operations in the region. Effective Jan. 1, 2021, Showa Denko Carbon Holding will take over Showa Denko Europe, becoming the surviving entity. It will then change its name to Showa Denko Europe. (c) Showa Denko

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read